Hyponatraemia
Hyponatraemia is a disorder of sodium homeostasis characterised by low levels of sodium (< 135 or 136 mmol/L). It's the most common electrolyte abnormality, affecting 3-10% of patients in the emergency department. It's usually mild and is self-limiting, but severe hyponatraemia is lethal.
| Hyponatraemia | |
|---|---|
| Other names | Hyponatremia |
| Definition | Serum sodium level < 136 mmol/L |
| Symptoms | Anything from headache and mild altered mental status to coma |
| Causes | Heart failure, liver failure, dehydration, and SIADH |
| Treatment | Water restriction, sodium repletion |
Grading of severity
| Sodium level | Severity |
|---|---|
| 136 - 130 | Mild |
| 129 - 120 | Moderate |
| > 120 | Severe |
Classification
Establishing the patient's fluid status and serum osmolality (tonicity) is important to determine the underlying cause. We usually distinguish between hypotonic, isotonic, and hypertonic hyponatraemia. In case of hypotonic hyponatraemia, the fluid status is essential in the evaluation.
Etiology
Hyponatraemia can occur secondary to many disorders.
- Isotonic hyponatraemia
- Hypertonic hyponatraemia
- Hyperglycaemia
- Intake of mannitol, sorbitol, glycerol, maltose
- Contrast material
For hypotonic hyponatraemia, possible causes depends on the fluid status:
| Hypovolaemic hypotonic hyponatraemia | Normovolaemic hypotonic hyponatraemia | Hypervolaemic hypotonic hyponatraemia |
|---|---|---|
| Extrarenal fluid loss (dehydration, diarrhoea, vomiting, burn injury) | Syndrome of inappropriate anti-diuretic hormone (SIADH) | Acute kidney injury or chronic kidney disease |
| Renal fluid loss (diuretic (especially thiazides), nephropathy, mineralocorticoid deficiency, cerebral salt wasting syndrome) | Postoperative hyponatraemia | Heart failure |
| Hypothyroidism | Liver failure | |
| Low sodium intake (usually in elderly or people with alcohol use disorder) | Nephrotic syndrome |
Hyponatraemia is most commonly hypotonic. The most common causes overall are heart failure, liver failure, dehydration, and SIADH.
Depending on whether the cause is acute or chronic, hyponatraemia can be acute or chronic as well. Hyponatraemia is acute if it has developed over 48 hours or less.
Pathophysiology
One of sodium's main functions is to maintain tonicity, i.e. the same osmolality in the intracellular and extracellular spaces. When hyponatraemia occurs, the plasma osmolality usually decreases while the intracellular osmolality remains. This causes fluid to flow from the extracellular space to the intracellular space, causing oedema. This is most dangerous in the brain. The symptoms and potential lethality of hyponatraemia is caused by swelling of brain cells, intracellular brain oedema.
Cells can compensate for the change in tonicity. When the osmolality of the extracellular space decreases, cells can release electrolytes (like potassium) and osmotically active organic molecules (like myoinositol and choline compounds) to decrease the intracellular osmolality to try to achieve isotonicity. However, this compensation takes several days, explaining why acute hyponatraemia is more dangerous than a chronic one.
Clinical features
Clinical features in hyponatraemia depends on the degree of intracellular brain oedema. As such, mild acute hyponatraemia or chronic hyponatraemia (even if moderate) usually does not lead to brain oedema and is therefore asymptomatic. However, if the sodium levels are severely decreased, or the drop in sodium level occurs suddenly, brain oedema occurs. The symptoms are non-specific. Typical symptoms include (in increasing order of severity):
- Dizziness
- Fatigue
- Headache
- Impaired mental status
- Seizures
- Coma
Diagnosis and evaluation
Determining the cause is the first priority.
Determining tonicity
To determine the cause, we must know the tonicity of the hyponatraemia. Evaluation of effective serum osmolality is important for this. The (non-effective) serum osmolality can be measured in a lab test, but this also counts so-called ineffective osmoles, which are osmotically active compounds which do not affect the movement of water between cells and extracellular fluid because these ineffective osmoles can freely cross cell membranes. Urea and ethanol are two such ineffective osmoles.
In any case, the effective serum osmolality can be calculated by either:
- Effective osmolality = serum glucose + 2 x serum sodium
- Effective osmolality = measured serum osmolality - (urea + ethanol)
We can then use this value to determine the tonicity of the hyponatraemia:
- Effective serum osmolality < 281 mosm/kg -> hypotonic hyponatraemia
- Effective serum osmolality 281-295 mosm/kg -> isotonic hyponatraemia
- Effective serum osmolality > 295 mosm/kg -> hypertonic hyponatraemia
... which can be used to narrow the list of possible causes.
Determining fluid status
Determining fluid or volume status also helps us determining the cause, especially if there is hypotonic hyponatraemia. Determining fluid status can be difficult, but there are some features which can help:
- Features of hypovolaemia
- Lower weight compared to normal
- Tachycardia or hypotension or orthostatic hypotension
- Increased capillary refill
- Weak peripheral pulse
- Decreased skin turgor
- Dry mucous membranes of the oral cavity and tongue
- Sunken fontanelle (in infants)
- Features of hypervolaemia
- Higher weight compared to normal
- Oedema (peripheral or pulmonary)
- Ascites
- Distended jugular vein
Evaluation of the skin turgor for volume status is unreliable in elderly, as they have decreased turgor regardless of fluid status.
Determining renal sodium loss
Measuring the level of sodium in the urine is important in the evaluation of hypovolaemic hypotonic hyponatraemia. High urine sodium (>25-40 mmol/L) points to renal disease, causing the kidney to excrete more sodium than necessary. Other possible causes include glucocorticoid and mineralocorticoid deficiency, diuretics, and cerebra salt wasting syndrome.
Low urine sodium (< 25 mmol/L) points to loss of sodium from places other than the kidney (extrarenal sodium loss), for example diarrhoea, vomiting, or third spacing of fluid.
Management
Mild hyponatraemia does not usually require hospitalisation, but moderate, severe, or symptomatic hyponatraemia requires hospitalisation. Sever hyponatraemia requires intensive care.
Treatment depends on the underlying cause. Any drugs which can contribute to hyponatraemia should be discontinued if possible. Fluid restriction and increased intake of dietary salt is usually sufficient, but fluid restriction should not be used in those who are hypovolaemic. People who have symptomatic hyponatraemia require hospital admission.
In moderate cases, intravenous infusion of isotonic (0,9%) NaCl can be considered. In severe hyponatraemia, hypertonic (3%) saline can be considered.
Rate of correction
Sodium levels must be corrected slowly to allow the body to reverse its compensatory mechanism to hypotonicity, especially in case of severe chronic hyponatraemia. Failure to do this will causes the serum osmolality to increase faster than the intracellular osmolality, which causes osmotic demyelination syndrome.
The sodium level should not increase more than (all of the following):
- 0,5 mmol/L per hour
- 10 mmol/L per the first 24 hours
- 18 mmol/L per the first 48 hours
In severe cases, the sodium level should increase even more slowly, not more than 6-8 units per 24 hour.
Complications
Osmotic demyelination syndrome
Osmotic demyelination syndrome (ODS), previously called central pontine myelinolysis, is a complication of too rapid correction of severe chronic hyponatraemia. This is rare in case of sodium levels above 120 mmol/L or if the hyponatraemia has occured within a few days (as the body's compensatory mechanisms haven't kicked in yet).
Symptoms of ODS occur a few days after the correction, and include cerebellar symptoms and other neurological deficits. Some may experience locked-in syndrome.